Save your place

Sign in to WhoBought

Please try again later.

Treace Medical Concepts, Inc. (TMCI) institutional ownership

Latest close $4.05 Jul 23, 2026
Market cap$336M 52-week range SectorHealthcare
Funds holding · Q1 2026
114
reported TMCI position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
59 buyers · 55 sellers

Treace Medical Concepts, Inc. (TMCI) price and institutional activity

Dates

Q1 2026

$0 bought by 59 investors
Gagnon Securities LLCAQR Capital Management LLC +57 more
$0 sold by 55 investors
CIBC Bancorp USA Inc.Gagnon Advisors, LLC +53 more
Bought Sold Totals per quarter; hover a bar for the names.

Treace Medical Concepts, Inc. (TMCI) institutional activity · 114

Investor Type Est. change Change Δ Own Date
CIBC Bancorp USA Inc. · Reduced
Change −17.0M Date Q1 2026
CIBC Bancorp USA Inc. Reduced· Q1 2026 −17.0M Q1 2026
Gagnon Securities LLC · Added
Change +2.1M Date Q1 2026
Gagnon Securities LLC Added· Q1 2026 +2.1M Q1 2026
Gagnon Advisors, LLC · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
Gagnon Advisors, LLC Exited· Q1 2026 −1.5M −100.0% Q1 2026
First Eagle Investment Management, LLC · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
First Eagle Investment Management, LLC Exited· Q1 2026 −1.5M −100.0% Q1 2026
William Blair Investment Management, LLC · Exited
Change −1.1M Δ Own −100.0% Date Q1 2026
William Blair Investment Management, LLC Exited· Q1 2026 −1.1M −100.0% Q1 2026
AQR Capital Management LLC · New
Change +1.1M Date Q1 2026
AQR Capital Management LLC New· Q1 2026 +1.1M Q1 2026
Bank of America Corp · Added
Change +900K Date Q1 2026
Bank of America Corp Added· Q1 2026 +900K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +614K +289.6% Q1 2026
Renaissance Technologies LLC New· Q1 2026 +523K Q1 2026
Millennium Management LLC · Reduced
Change −355K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −355K Q1 2026
Acadian Asset Management LLC · Added
Change +279K Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +279K Q1 2026
Marshall Wace, LLP · New
Change +265K Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +265K Q1 2026
Jacobs Levy Equity Management, Inc · New
Change +264K Date Q1 2026
Jacobs Levy Equity Management, Inc New· Q1 2026 +264K Q1 2026
UBS Group AG · Added
Change +249K Date Q1 2026
UBS Group AG Added· Q1 2026 +249K Q1 2026
Wealth Enhancement Advisory Services, LLC · Exited
Change −242K Δ Own −100.0% Date Q1 2026
Wealth Enhancement Advisory Services, LLC Exited· Q1 2026 −242K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 114

Famous investor activity in Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts, Inc. (TMCI) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Treace John T. · Director Buy +$93K
Price $4.04 Qty +23K Owned 7.4M Trade date Jun 11, 2026 Filed date Jun 11, 2026
Treace John T. Director Buy $4.04 +23K +$93K 7.4M Jun 11, 2026 Jun 11, 2026
Treace John T. · Director Buy +$118K
Price $4.02 Qty +29K Owned 7.4M Trade date Jun 10, 2026 Filed date Jun 11, 2026
Treace John T. Director Buy $4.02 +29K +$118K 7.4M Jun 10, 2026 Jun 11, 2026
Treace John T. · Director Buy +$178K
Price $3.56 Qty +50K Owned 7.3M Trade date Jun 1, 2026 Filed date Jun 1, 2026
Treace John T. Director Buy $3.56 +50K +$178K 7.3M Jun 1, 2026 Jun 1, 2026
Treace John T. · Director Buy +$185K
Price $3.02 Qty +61K Owned 7.3M Trade date May 28, 2026 Filed date May 28, 2026
Treace John T. Director Buy $3.02 +61K +$185K 7.3M May 28, 2026 May 28, 2026
Treace John T. · Director Buy +$143K
Price $2.87 Qty +50K Owned 7.2M Trade date May 27, 2026 Filed date May 28, 2026
Treace John T. Director Buy $2.87 +50K +$143K 7.2M May 27, 2026 May 28, 2026
Treace John T. · Director Buy +$13K
Price $2.79 Qty +5K Owned 7.2M Trade date May 26, 2026 Filed date May 28, 2026
Treace John T. Director Buy $2.79 +5K +$13K 7.2M May 26, 2026 May 28, 2026
Bakewell John K. · Director Grant (A) 30K
Owned 204K Trade date May 19, 2026 Filed date May 19, 2026
Bakewell John K. Director Grant (A) 30K 204K May 19, 2026 May 19, 2026
Kiernan Jane E. · Director Grant (A) 30K
Owned 94K Trade date May 19, 2026 Filed date May 19, 2026
Kiernan Jane E. Director Grant (A) 30K 94K May 19, 2026 May 19, 2026
Berry Lance A. · Director Grant (A) 30K
Owned 75K Trade date May 19, 2026 Filed date May 19, 2026
Berry Lance A. Director Grant (A) 30K 75K May 19, 2026 May 19, 2026
Jain Deepti · Director Grant (A) 30K
Owned 100K Trade date May 19, 2026 Filed date May 19, 2026
Jain Deepti Director Grant (A) 30K 100K May 19, 2026 May 19, 2026
Hamilton Lawrence W. · Director Grant (A) 30K
Owned 74K Trade date May 19, 2026 Filed date May 19, 2026
Hamilton Lawrence W. Director Grant (A) 30K 74K May 19, 2026 May 19, 2026
Hanna Betsy · Director Grant (A) 30K
Owned 75K Trade date May 19, 2026 Filed date May 19, 2026
Hanna Betsy Director Grant (A) 30K 75K May 19, 2026 May 19, 2026
Treace John T. · Director Buy +$161K
Price $2.62 Qty +62K Owned 7.2M Trade date May 14, 2026 Filed date May 14, 2026
Treace John T. Director Buy $2.62 +62K +$161K 7.2M May 14, 2026 May 14, 2026
Treace John T. · Director Buy +$121K
Price $2.46 Qty +49K Owned 7.1M Trade date May 13, 2026 Filed date May 14, 2026
Treace John T. Director Buy $2.46 +49K +$121K 7.1M May 13, 2026 May 14, 2026
Treace John T. · Director Buy +$93K
Price $2.17 Qty +43K Owned 7.0M Trade date May 12, 2026 Filed date May 14, 2026
Treace John T. Director Buy $2.17 +43K +$93K 7.0M May 12, 2026 May 14, 2026
15 of 26
15 of 26 Sign in to continue to older insider transactions.

Treace Medical Concepts, Inc. (TMCI) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Treace John T. 11.8M
% of shares outstanding 18.9% Filing date Nov 7, 2024
Treace John T. 11.8M 18.9% Nov 7, 2024
Armistice Capital, LLC 6.4M
% of shares outstanding 9.8% Filing date May 15, 2026
Armistice Capital, LLC 6.4M 9.8% May 15, 2026
Gagnon Securities LLC 3.9M
% of shares outstanding 6.2% Filing date Feb 12, 2026
Gagnon Securities LLC 3.9M 6.2% Feb 12, 2026
BlackRock Inc. 3.7M
% of shares outstanding 6.0% Filing date Jan 29, 2024
BlackRock Inc. 3.7M 6.0% Jan 29, 2024
Bank of America Corp 3.5M
% of shares outstanding 5.5% Filing date May 14, 2026
Bank of America Corp 3.5M 5.5% May 14, 2026
Morgan Stanley 3.2M
% of shares outstanding 5.2% Filing date Nov 8, 2024
Morgan Stanley 3.2M 5.2% Nov 8, 2024
Vanguard Group Inc 2.7M
% of shares outstanding 4.4% Filing date Nov 12, 2024
Vanguard Group Inc 2.7M 4.4% Nov 12, 2024
Treace John R 2.4M
% of shares outstanding 4.3% Filing date Feb 13, 2023
Treace John R 2.4M 4.3% Feb 13, 2023
8 of 11

Treace Medical Concepts, Inc. (TMCI) ownership FAQ

Who owns TMCI?

114 reporting institutions disclosed TMCI position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.